chr8-38172015-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 4P and 4B. PP3_StrongBS2
The NM_014462.3(LSM1):āc.65T>Cā(p.Leu22Pro) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000434 in 1,611,442 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 12/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_014462.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LSM1 | NM_014462.3 | c.65T>C | p.Leu22Pro | missense_variant | 2/4 | ENST00000311351.9 | NP_055277.1 | |
LSM1 | NR_045492.2 | n.238T>C | non_coding_transcript_exon_variant | 2/3 | ||||
LSM1 | NR_045493.1 | n.197T>C | non_coding_transcript_exon_variant | 2/4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LSM1 | ENST00000311351.9 | c.65T>C | p.Leu22Pro | missense_variant | 2/4 | 1 | NM_014462.3 | ENSP00000310596.4 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152250Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000403 AC: 1AN: 248346Hom.: 0 AF XY: 0.00000745 AC XY: 1AN XY: 134306
GnomAD4 exome AF: 0.00000343 AC: 5AN: 1459192Hom.: 0 Cov.: 29 AF XY: 0.00000275 AC XY: 2AN XY: 725956
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152250Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74384
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 07, 2023 | The c.65T>C (p.L22P) alteration is located in exon 2 (coding exon 2) of the LSM1 gene. This alteration results from a T to C substitution at nucleotide position 65, causing the leucine (L) at amino acid position 22 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at